Prior work has revealed that PAK1 is essential for RAS-driven cancer cells, including those of CRC [20,22], and inhibition of PAK1 sensitizes RAS- and GNAQ-mutant cells to MAPK cascade inhibitors [22,28]. This evidence concerns the gene PAK1 and colorectal carcinoma.